Letter: The role of sub-clinical inflammation and TRPV1 in the development of IBS-like symptoms in ulcerative colitis in remission

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 5, 2013, Pages 560-561

  Keszthelyi, D ^a   Jonkers, D M ^a   Hamer, H M ^a   Masclee, A A M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; VANILLOID RECEPTOR 1;

ABDOMINAL PAIN; FECES ANALYSIS; HUMAN; INTRACELLULAR SIGNALING; IRRITABLE COLON; LETTER; MOLECULAR PATHOLOGY; MUCOSA INFLAMMATION; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REMISSION; ULCERATIVE COLITIS; UPREGULATION;

EID: 84882415878     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12409     Document Type: Letter

References (5)

1. Berrill JW, Green JT, Hood K, Campbell AK,. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Aliment Pharmacol Ther 2013; 38: 44-51.
2. Jonefjall B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M,. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil 2013; doi: 10.1111/nmo.12163 [Epub ahead of print].
3. Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley EM, Shanahan F,. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 2010; 105: 1789-94.
4. Keszthelyi D, Troost FJ, Jonkers DM, et al,. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Eur J Pain 2013; doi: 10.1002/j.1532-2149.2013.00309.x [Epub ahead of print].
5. Akbar A, Yiangou Y, Facer P, et al,. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 2010; 59: 767-74.